Photo taken from The Babak Lab/LinkedIn
Jul 7, 2024, 14:59
Advancements in Oncology and Cancer Understanding – The Babak Lab
The Babak Lab made the following post on LinkedIn:
“Weekly Digest Advancements in Oncology and Cancer Understanding
Stay informed about the latest advancements in cancer treatment and understanding to support yourself better, your loved ones, and your community with The Babak Lab.
- Pediatric Oncology Breakthrough: FDA Approves Lutathera for Adolescents
A monumental approval expands treatment options for young patients with rare neuroendocrine tumors. Discover how this new FDA approval brings hope and improved outcomes for adolescents with GEP-NETs. Understand the importance of advancing personalized treatments in pediatric oncology. - CAR T-Cell Therapy: Safe and Promising with Essential Monitoring
Gain insights from a recent NEJM Group study that underscores the safety and effectiveness of CAR T-cell therapy while highlighting the importance of ongoing patient monitoring to enhance treatment outcomes. - Understanding Cancer Staging: The TNM System Explained
Learn how cancer stages are determined and what they mean for treatment and prognosis. This knowledge empowers patients and their families with essential information to navigate a cancer diagnosis.”
Source: The Babak Lab/LinkedIn
adolescents
cancer
Cancer Diagnosis
Cancer Education
cancer prognosis
Cancer Staging
cancer treatment
cancer understanding
CAR T-cell therapy
FDA approval
GEP-NETS
Lutathera
Maria Babak
NEJM Group
neuroendocrine tumors
OncoDaily
Oncology
oncology advancements
patient monitoring
pediatric oncology
personalized treatments
The Babak Lab
TNM system
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14